Karkkainen et al., 2001 - Google Patents
Molecular regulation of lymphangiogenesis and targets for tissue oedemaKarkkainen et al., 2001
- Document ID
- 12705873007642740321
- Author
- Karkkainen M
- Jussila L
- Alitalo K
- Ferrell R
- Finegold D
- Publication year
- Publication venue
- Trends in molecular medicine
External Links
Snippet
19 Review for lymphatic development, and that the blood vascular and lymphatic systems subsequently employ distinct regulatory proteins. Podoplanin, an integral membrane protein first found in glomerular epithelial cells, has also been shown to be specifically expressed in …
- 210000001519 tissues 0 title description 17
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karkkainen et al. | Molecular regulation of lymphangiogenesis and targets for tissue oedema | |
| Saharinen et al. | Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation | |
| Oliver | Lymphatic vasculature development | |
| Tammela et al. | Molecular lymphangiogenesis: new players | |
| Tian et al. | Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming | |
| Furtado et al. | Lymphotoxin β receptor signaling is required for inflammatory lymphangiogenesis in the thyroid | |
| Trojanowska | Role of PDGF in fibrotic diseases and systemic sclerosis | |
| Wigle et al. | Prox1 function is required for the development of the murine lymphatic system | |
| Rey et al. | Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia | |
| Takashima et al. | Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis | |
| Li et al. | VEGF-B: a survival, or an angiogenic factor? | |
| Yoshida et al. | Induction of IL-8, MCP-1, and bFGF by TNF-α in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation | |
| Hou et al. | PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets | |
| Alitalo et al. | Lymphangiogenesis in development and human disease | |
| Arsic et al. | Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors | |
| Li et al. | Complicated life, complicated VEGF-B | |
| Lindner et al. | A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor–B chain mRNA | |
| Scharpfenecker et al. | The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism | |
| Desjarlais et al. | MicroRNA-150 modulates ischemia-induced neovascularization in atherosclerotic conditions | |
| Grépin et al. | Molecular mechanisms of resistance to tumour anti‐angiogenic strategies | |
| Hoyer et al. | Bone marrow endothelial cells regulate myelopoiesis in diabetes mellitus | |
| Oliver et al. | Lymphatic vasculature development: current concepts | |
| Choi et al. | Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration | |
| Mehta et al. | HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis | |
| Saharinen et al. | Molecular regulation of lymphangiogenesis |